Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04053283
Title First in Human Study With NG-641, an Oncolytic Transgene Expressing Adenoviral Vector
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors PsiOxus Therapeutics Ltd
Indications

carcinoma

Therapies

NG-641

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.